Prep4all

Gilead Sciences agreed in principle to pay $40 million to more than 2,600 people living with HIV who claimed the company boosted profits by marketing an HIV drug without disclosing harmful side effects while delaying development of a safer alternative treatment.

Gilead to pay $40 million to settle claims it delayed newer HIV treatment to boost profits Gilead was accused of boosting profits by marketing an HIV drug without disclosing harmful side effects while delaying development of a safer alternative.

Register now at: https://syncconference.org

Join us at SYNC 2024 for a special institute “Mobilizing Towards PrEP Access For All.”

Hosted by PrEP4All, this Institute will focus on several ways that participants can immediately engage in the movement for equitable PrEP access.

Since 2018, PrEP4All has led the charge for a federally-funded National PrEP Program for un- and underinsured individuals, leading to the Biden Administration calling for $9.8 billion over ten years for the “PrEP For All To End The HIV Epidemic” initiative in the White House FY2023 budget request. PrEP4All and our partners have since mobilized with legislators, federal stakeholders, and community members to push Congress to approve funding for a National PrEP Program. We are also leaders in the fight to ensure access for insured individuals, convening urgent community town halls in response to the threats posed by Braidwood v. Becerra.

Join PrEP4All for an interactive institute that will focus on uplifting the voices of PrEP users, providers, and community members to address policy and cost barriers that impact PrEP access for uninsured and underinsured individuals, as well as looming legal threats impacting cost and access for insured individuals.

Join us for an evening of fun, glamor, and generosity at the PrEP4All No Pants Gala Fundraiser!

Get ready to ditch the pants and elevate your evening attire for a cause that truly matters. On May 20th, 2024, we’re hosting a fabulous gala to raise funds and awareness for PrEP4All, an organization dedicated to making PrEP accessible to all individuals vulnerable to HIV through a National PrEP program. Whether wearing your flashiest briefs, a tasteful bathing suit, a kilt, or a tutu; we’re excited to see what pants-free looks people bring.

Purchase tickets at https://www.redeyetickets.com/prep4all-no-pants-gala/

Can’t attend? You can still support our advocacy towards a National PrEP Program by donating at https://prep4all.org/donate/no-pants-gala/

Read our latest report, "Toward PrEP Access For All," now available for download on southernaidscoalition.org and prep4all.org.

Overall HIV incidence dropped by 12% between 2017 and 2021, yet the gap between non-Hispanic whites and BIPOC individuals continues to widen.

Join the conversation! Share your thoughts, experiences, and ideas using .

Read the full report: https://southernaidscoalition.org/press/breaking-barriers-advancing-prep-access-for-all-in-the-southern-u-s/
Together, we can – and will – secure equitable PrEP access for all!

We Can’t End HIV in the United States Without Equitable PrEP Access: Strategies for Success.

Date: Friday, April 26, 2024
Time: 1pm to 2:30pm ET

Register now: https://tinyurl.com/equitableprep

A collaboration between HIVMA, PrEP4All and The Choice Agenda this webinar will assess some of the key challenges to delivering PrEP in the United States equitably, including cost, the complexities of our health care system, and other factors that inhibit uptake amongst the most vulnerable communities. Strategies to address these challenges will be offered, with lots of time for QA, discussion and much-needed debate. Please join us!

Speakers:
Dr. Lorraine Dean, Johns Hopkins University, Department of Epidemiology

Dr. Rupa Patel, Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention

Dr. Patrick Sullivan, Rollins School of Public Health, Emory University

Moderator:
Dr. Greg Millet, amfAR

PrEP4All excited to announce the launch of our newest initiative, the PrEP Users’ Union.

An extension of our campaign launched in Summer of 2023, we are seeking to elevate the voices of PrEP users in key policy discussions, especially around the National PrEP Program.

For more information, visit prep4all.org/prepsaves.

Available for Download

Breaking Barriers: Advancing PrEP Access for All in
the Southern U.S.

In partnership with Southern AIDS Coalition, we’re thrilled to unveil our groundbreaking report, “Toward PrEP Access for All: An analysis of policies, approaches, and strategies in the Southern United States.”

This report delves into the crucial steps needed to ensure everyone has equitable access to PrEP.

Key Findings:
• Key barriers to equitable PrEP access
• A closer look at Medicaid & Medical Coverage
• Unpacking the role of Provider Networks
• Strategies in Communications, marketing, and
Demand Creation

Read the full report: https://prep4all.org/publications/

Together, we can – and will – secure equitable
PrEP access for all!

March 10th is National Women & Girls HIV/AIDS Awareness Day. For , tell your leaders in Congress to and support a National PrEP Program at bit.ly/savehivfundingnow!

ADAP Advocacy is seeking participants for a short, online survey to better understand patient perspectives about long-acting injectable (LAIs) medications for the prevention of HIV/AIDS.

Survey: https://cutt.ly/PrEP-Survey

"It is dangerous for patients, providers, and payers to allow Gilead marketing and other promotional activities that misleadingly imply that Descovy is a better PrEP formulation for all PrEP users simply because it is “newer” to dictate coverage policy."

PrEP Coverage Should Follow Clinical Guidelines, Not Pharmaceutical Agenda: A Response To Hughes | Health Affairs Forefront We disagree that the US Preventive Services Task Force has the authority or expertise to make recommendations with regard to whether every available and clinically effective pre-exposure prophylaxis medication should be covered without utilization management.

This Thursday at 7pm ET, Prep4all will be hosting an end of year discussion for our supporters and allies highlighting our successes in 2023 and our advocacy plans for 2024.

We continue to make significant progress toward a National PrEP Program; if you'd like to hear about our work as well as perspectives from special guests (including Brad Korten, Legislative Director for Rep. Bonnie Watson Coleman) on PrEP policy priorities for 2024 we're asking everyone to:

1. RSVP by going to this link: https://bit.ly/prepfor2024
2. Consider making a donation to PrEP4All to support our work into next year: https://prep4all.org/donate/nov2023/

For World AIDS Day, Sir Elton John brings awareness to the need for a National PrEP Program and the impact of the drastic cuts to HIV funding proposed by Congress. Let your representatives in Congress to at bit.ly/savehivfundingnow.

World AIDS Day 2023: Save HIV Funding Funding for HIV programs are at risk of being cut by Congress, threatening the global progress we have made. On this World AIDS Day, we’re urging Congress to...

“I’m old enough to remember, as a young member of ACT UP, the first World AIDS Day 35 years ago,” said Peter Staley, Board Member of PrEP4All. “Much has been accomplished since then, but we won’t end AIDS until the health inequities that today’s statistics highlight become the primary focus of our fight.”

Health Department Releases 2022 HIV Surveillance Annual Report, Commemorates 2023 World AIDS Day - NYC Health New HIV diagnoses in New York City in 2022 down 17% since 2018 and down 72% since 2001, with new diagnoses remaining stable from 2021 to 2022

This , support PrEP4All in the fight to and to pass a federal-funded National PrEP Program.

PrEP4All takes no corporate funding, which means we rely on supporters like you to keep our work going.

Donate at bit.ly/givep4a2023!

PrEP4All stands proudly with the transgender and gender diverse community today and every day.

This Trans Day of Remembrance, we call on the CDC to greatly improve visibility of transgender people in all communications regarding estimates of PrEP access in key populations. Recent releases (https://www.hiv.gov/blog/expanding-prep-coverage-in-the-united-states-to-achieve-ehe-goals/) failed to refer to trans people in any capacity. This is unacceptable in 2023.

There is so much more work to do to make sure PrEP is accessible to those who need it most, that’s why we continue to fight for a National PrEP Program and to prevent Congress from passing HIV funding cuts.

HIV prevention drugs for older Americans may be free under new Biden proposal The U.S. government has proposed that Medicare fully cover preexposure prophylaxis drugs that prevent HIV to help end new infections.

Thirty-five years ago today, about 1,500 activists protested the FDA’s failure to approve medications to fight AIDS. In 2023, decades later, activists are fighting to protect funding to end the HIV epidemic.

PrEP4All Executive Director Jeremiah Johnson tells The Guardian that he believes Act Up still signifies “the importance of being creative with our responses, of punching above our weight and of not giving up even in the darkest moments”.

‘The start of the national Aids movement’: Act Up’s defining moment in q***r protest history Desperate Aids patients and their allies in the 80s confronted the US government and ushered in a new era of forceful protests

Happy Birthday and congratulations to PrEP4All’s Executive Director Jeremiah Johnson for being recognized as a Fierce Pharma 2023 Fierce 50 Honoree for his work towards making PrEP and HIV treatment medications more accessible.

As a birthday gift and to celebrate his work towards a federally-funded National PrEP Program, you can make a donation to PrEP4All at https://prep4all.org/donate/may2023/. 🎉🎂🥳🎈🎊🎁

PrEP4All Executive Director Jeremiah Johnson notes that when drug companies are criticized for access and pricing issues, they deflect by touting their charitable donations, which represent “a very small percentage of their overall profits.”

Can Solidarity Keep the HIV/AIDS Community Independent From Drug Companies? Longtime activist Suzy Subways asks us to keep our criticism of Big Pharma strong—even when that’s where we get our funding.

House Representatives in Congress are proposing $767 million in cuts to HIV funding, setting us back on any progress towards ending the HIV epidemic. Saving HIV funding will save lives! Proposed cuts to HIV funding will have a devastating impact on lifesaving HIV treatment and prevention initiatives. Tell your members of Congress to at bit.ly/savehivfundingnow.

TELL CONGRESS #SAVEHIVFUNDING! (To Be Entered)

House Appropriators are calling for $767 million in cuts to HIV efforts, while global HIV funding is still threatened! Join PrEP4All and a coalition of HIV advocates and organizations for the Press Conference in Washington, DC on Sept. 5 by registering at bit.ly/savehivfunding.

PrEP4All applauds long-acting injectable PrEP receiving a grade A rating from USPSTF, but we need the federal government to step up to enforce coverage from insurers.

Panel’s endorsement paves the way for insurance coverage of injectable PrEP A national panel of medical experts endorsed an injectable version of the HIV prevention medication known as PrEP in a significant move that will require

SAVE THE DATE: Join PrEP4All, along with a coalition of domestic and global HIV organizations for a press conference on Tuesday, Sept. 5 at 4PM ET in Washington, D.C. to tell Congress to !

SAVE THE DATE! PRESS CONFERENCE TO #SAVEHIVFUNDING! SAVE THE DATE PRESS CONFERENCE TO ! When: Tuesday, September 5th @ 4PM ET Where: Washington DC- specific location to be announced (permit applications are pending) Register/Sign up for updates *Attendees encouraged to wear red for solidarity* PrEP4All– in partnership with AVAC, PrEP...

BREAKING: Jeremiah Johnson, Executive Director of PrEP4all, said the impact of the task force’s support for Apretude “will depend largely on how seriously the federal government takes enforcement of coverage with insurers.”

Insurers must cover injectable HIV prevention drug — unless courts void mandate The federal judiciary could strip a health task force’s effective authority to require insurers cover preventive interventions, including the HIV PrEP drug Apretude.

PrEP4All Applauds Announcement of Pioneering PrEP Researcher to Lead NIAID

PrEP4All Applauds Announcement of Pioneering PrEP Researcher to Lead NIAID For Immediate Release Wednesday, August 2nd, 2023 For media inquiries please email Michael Chancley at [email protected] PrEP4All welcomes the announcement of Dr. Jeanne Marrazzo to fill the role…

Activist Victory: PrEP4All, AVAC, HIVMA, and the PrEP In Black America Coalition Applaud Senate Proposal to Increase Key HIV Funding, Build National PrEP Program

Activist Victory: PrEP4All, AVAC, HIVMA, and the PrEP In Black America Coalition Applaud Senate Proposal to Increase Key HIV Funding, Build National PrEP Program For Immediate Release Friday, July 28, 2023 For Media Inquiries, contact Michael Chancley at [email protected]. Soundly rejecting House efforts to gut HIV funding, yesterday the Senate Labor…

NYTimes: Years Ago, PrEP4All Correctly Called Out Gilead's Intentional Delay In Developing Potentially Safer HIV Treatment to US Patent and Trademark Office

NYTimes: Years Ago, PrEP4All Correctly Called Out Gilead’s Intentional Delay In Developing Potentially Safer HIV Treatment to US Patent and Trademark Office July 25th, 2023- For media requests please email Jeremiah Johnson at [email protected] or Chris Morten at [email protected] On Saturday July 22, a New York Times front-page investigation…